Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.4103/jfmpc.jfmpc_1512_20 http://scihub22266oqcxt.onion/10.4103/jfmpc.jfmpc_1512_20 33532418!7842439!33532418     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Family+Med+Prim+Care 2020 ; 9 (11): 5705-5710 Nephropedia Template TP {{tp|p=33532418|t=2020. Does COVID-19 antibody serology testing correlate with disease severity? An analytical descriptive retrospective study |pdf=|usr=}}{{33532418}} gab.com Text Does COVID-19 antibody serology testing correlate with disease severity An analytical descriptive retrospective study JO: J Family Med Prim Care http://www.kidney.de/pget.php?&tw=1&pmid=33532418 #FOAvip AIM: To find out if there is any correlation between COVID-19 antibody serological testing and symptom severity. METHODS: This study is a case series of 44 consecutive patients confirmed with COVID-19 who are divided into a group of 23 patients with mild disease and a group of 21 patients with severe disease. All 44 samples were confirmed positive SARS-CoV-2. Subsequent recombinant SARS-CoV-2 S1/S2 IgG test was performed for all patients and all patients developed neutralizing antibodies with altered range. MAIN OUTCOMES: IgG level and its correlation with disease severity, demographic data, underlying comorbidities, clinical presentation, and treatment comparison between mild and severe disease groups. RESULTS: Quantitative SARS COV-2 IgG was significantly higher in moderate and severe disease groups compared with those in the mild disease group. COVID-19 infection was more prevalent in male, Saudi nationals and smokers with comorbidities and higher inflammatory markers are more in the severe group than in the mild group which necessitates more management options to be taken for severe group patients. CONCLUSION: IgG antibody level was higher in the severe disease group. Also, the study showed significant differences between the mild and severe disease groups in terms of demographic, clinical, and management variables. Twit Text FOAVip Does COVID-19 antibody serology testing correlate with disease severity An analytical descriptive retrospective study ????J Family Med Prim Care http://www.kidney.de/pget.php?&tw=1&pmid=33532418 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33532418 #FOAvip English Wikipedia <ref>{{Cite pmid|33532418}}</ref> Does COVID-19 antibody serology testing correlate with disease severity? An analytical descriptive retrospective study #MMPMID33532418 Ghoraba MA; Hazazi AM; Albadi MA; Ghoraba AM; Al Shehah AA J Family Med Prim Care 2020[Nov]; 9 (11): 5705-5710 PMID33532418show ga AIM: To find out if there is any correlation between COVID-19 antibody serological testing and symptom severity. METHODS: This study is a case series of 44 consecutive patients confirmed with COVID-19 who are divided into a group of 23 patients with mild disease and a group of 21 patients with severe disease. All 44 samples were confirmed positive SARS-CoV-2. Subsequent recombinant SARS-CoV-2 S1/S2 IgG test was performed for all patients and all patients developed neutralizing antibodies with altered range. MAIN OUTCOMES: IgG level and its correlation with disease severity, demographic data, underlying comorbidities, clinical presentation, and treatment comparison between mild and severe disease groups. RESULTS: Quantitative SARS COV-2 IgG was significantly higher in moderate and severe disease groups compared with those in the mild disease group. COVID-19 infection was more prevalent in male, Saudi nationals and smokers with comorbidities and higher inflammatory markers are more in the severe group than in the mild group which necessitates more management options to be taken for severe group patients. CONCLUSION: IgG antibody level was higher in the severe disease group. Also, the study showed significant differences between the mild and severe disease groups in terms of demographic, clinical, and management variables. äDoes COVID-19 antibody serology testing correlate with disease severit(epmc).pdf DeepDyve Pubget Overpricing